coronary syndrome - Thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Randomized controlled trial", CIRCULATION, vol.116, no.15, October 2007 (2007-10), pages 1647-1652, XP002631256, ISSN: 0009-7322, GRAMLEY FELIX ET AL: "Recent advances in the pharmacological treatment of cardiac arrythmias.", DRUGS OF TODAY, vol.45, no.11, November 2009 (2009-11), pages 807-824, XP002631257, BARCELONA, SPAIN ISSN: 1699-3993, BURASHNIKOV ALEXANDER ET AL: "Author Manuscript:Atrial -selective sodium channel block for the treatment of atrial fibrillation.", NIH Public Access, June 2009 (2009-06), pages 1-25, XP002631258, Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov/pmc/articl es/PMC2756337/pdf/nihms125373.pdf [retrieved on 2011-04-05], KUMAR KAPIL ET AL: "New and emerging antiarrhythmic drugs for atrial fibrillation: what may become available to the clinician in the near future.", CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, vol.11, no.5, October 2009 (2009-10), pages 373-380, XP002631255, ISSN: 1534-3189, HOHNLOSER STEFAN H ET AL: "Effect of dronedarone on cardiovascular events in atrial fibrillation", NEW ENGLAND JOURNAL OF MEDICINE, vol.360, no.7, 12 February 2009 (2009 -02-12), pages 668-678, XP002604030, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US ISSN: 1533-4406, DOI: 10.1056/NEJMOA0803778, WO-A1-2009/150535, FOR THE ERATO STUDY INVESTIGATORS ET AL: "Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study", AMERICAN HEART JOURNAL, vol.156, no.3, September 2008 (2008-09), pages 527.E1-527.E9, XP025470440, MOSBY- YEAR BOOK INC, US ISSN: 0002-8703, DOI: 10.1016/J.AHJ.2008.06.010 [retrieved on 2008-08-27], SICOURI S ET AL: "Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations", HEART RHYTHM, vol.5, no.7, July 2008 (2008-07), pages 1019-1026, XP022819454, ELSEVIER, US ISSN: 1547-5271, DOI: 10.1016/J.HRTHM.2008.03.018 [retrieved on 2008-03-21]

Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/